6FA Stock Overview
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Semler Scientific, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$25.20 |
| 52 Week High | US$49.20 |
| 52 Week Low | US$20.80 |
| Beta | 0.89 |
| 1 Month Change | -8.03% |
| 3 Month Change | -37.31% |
| 1 Year Change | 14.55% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -76.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6FA | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 5.0% | 1.7% | 1.7% |
| 1Y | 14.5% | -7.7% | 2.3% |
Return vs Industry: 6FA exceeded the German Medical Equipment industry which returned -9.5% over the past year.
Return vs Market: 6FA exceeded the German Market which returned 2.2% over the past year.
Price Volatility
| 6FA volatility | |
|---|---|
| 6FA Average Weekly Movement | 10.6% |
| Medical Equipment Industry Average Movement | 4.6% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6FA's share price has been volatile over the past 3 months.
Volatility Over Time: 6FA's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 92 | Doug Murphy-Chutorian | www.semlerscientific.com |
Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing.
Semler Scientific, Inc. Fundamentals Summary
| 6FA fundamental statistics | |
|---|---|
| Market cap | €177.98m |
| Earnings (TTM) | €19.23m |
| Revenue (TTM) | €63.71m |
9.1x
P/E Ratio2.7x
P/S RatioIs 6FA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6FA income statement (TTM) | |
|---|---|
| Revenue | US$68.18m |
| Cost of Revenue | US$6.98m |
| Gross Profit | US$61.20m |
| Other Expenses | US$40.62m |
| Earnings | US$20.58m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | 2.93 |
| Gross Margin | 89.76% |
| Net Profit Margin | 30.19% |
| Debt/Equity Ratio | 0% |
How did 6FA perform over the long term?
See historical performance and comparison